$125 | Single User
$250 | Site License
$375 | Global License

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 22 May 2019 | 232096 | In Stock
Related Topics: FDA

Introduction

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

Terumo Corp Key Recent Developments

Feb 26,2019: Terumo to construct new facilities at its Vietnamese factory -15 billion yen investment to strengthen interventional therapeutic related production

Feb 07,2019: Terumo BCT opens first regional office in Sub-Saharan Africa

Nov 14,2018: Terumo announces GMP certification has been awarded for the manufacturing and filling of premixed intravenous solutions from the FDA (U.S.A.)

Oct 09,2018: UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents

    List of Tables

    List of Figures

    Section 1 - About the Company

    Terumo Corp - Key Facts

    Terumo Corp - Key Employees

    Terumo Corp - Key Employee Biographies

    Terumo Corp - Key Operational Employees

    Terumo Corp - Major Products and Services

    Terumo Corp - History

    Terumo Corp - Company Statement

    Terumo Corp - Locations And Subsidiaries

    Head Office

    Other Locations & Subsidiaries

    Joint Venture

    Section 2 – Company Analysis

    Company Overview

    Terumo Corp - Business Description

    Business Segment: Blood Management Company

    Overview

    Performance

    Business Segment: Cardiac and Vascular Company

    Overview

    Performance

    Business Segment: General Hospital Company

    Overview

    Performance

    Geographical Segment: Americas

    Performance

    Geographical Segment: Asia and Others

    Performance

    Geographical Segment: Europe

    Performance

    Geographical Segment: Japan

    Performance

    R&D Overview

    Terumo Corp - Corporate Strategy

    Terumo Corp - SWOT Analysis

    SWOT Analysis - Overview

    Terumo Corp - Strengths

    Terumo Corp - Weaknesses

    Terumo Corp - Opportunities

    Terumo Corp - Threats

    Terumo Corp - Key Competitors

    Section 3 – Company Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Performance Chart

    Financial Performance

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 – Company’s Lifesciences Financial Deals and Alliances

    Terumo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

    Terumo Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

    Terumo Corp, Recent Deals Summary

    Section 5 – Company’s Recent Developments

    Feb 26, 2019: Terumo to construct new facilities at its Vietnamese factory -15 billion yen investment to strengthen interventional therapeutic related production

    Feb 07, 2019: Terumo BCT opens first regional office in Sub-Saharan Africa

    Nov 14, 2018: Terumo announces GMP certification has been awarded for the manufacturing and filling of premixed intravenous solutions from the FDA (U.S.A.)

    Oct 09, 2018: UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence

    Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor

    Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor

    Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation

    Jul 04, 2018: Terumo Announces Shipping Delays for Products from Ashitaka Factory

    May 11, 2018: Terumo Appoints its U.S. based Subsidiary's Associate as the Fifth Terumo Fellow

    Apr 23, 2018: Vascutek and Bolton Medical Merge as ‘Terumo Aortic’

    Section 6 – Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

List Of Tables
in Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

Terumo Corp, Key Facts

Terumo Corp, Key Employees

Terumo Corp, Key Employee Biographies

Terumo Corp, Key Operational Employees

Terumo Corp, Major Products and Services

Terumo Corp, History

Terumo Corp, Other Locations

Terumo Corp, Subsidiaries

Terumo Corp, Joint Venture

Terumo Corp, Key Competitors

Terumo Corp, Ratios based on current share price

Terumo Corp, Annual Ratios

Terumo Corp, Annual Ratios (Cont...1)

Terumo Corp, Annual Ratios (Cont...2)

Terumo Corp, Interim Ratios

Terumo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Terumo Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Terumo Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

Terumo Corp, Performance Chart (2015 - 2019)

Terumo Corp, Ratio Charts

Terumo Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Terumo Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

Additional Details

Publisher

Global Data

Publisher Information

Reference

232096 |

Number of Pages

61

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Terumo Cardiovascular Systems Corporation - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Cardiovascular Systems Corporation (TCSC) is a provider of medical equipment and devic...
14 Apr 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
14 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
13 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
12 Apr 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
10 Mar 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
09 Mar 2016 by Global Data USD $250 More Info
Terumo Cardiovascular Systems Corporation - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Cardiovascular Systems Corporation (TCSC) is a provider of medical equipment and devic...
24 Feb 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryTerumo BCT, Inc. (Terumo BCT), a subsidiary of Terumo Corporation, provides blood component, ...
24 Feb 2016 by Global Data USD $250 More Info
Terumo Corporation (4543) - Medical Equipment - Deals and Alliances Profile
SummaryTerumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing ...
24 Feb 2016 by Global Data USD $250 More Info
Terumo BCT, Inc. - Strategic SWOT Analysis Review
Terumo BCT, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’...
23 Feb 2016 by Global Data USD $125 More Info

This report is published by Global Data

Download Free Report Summary PDF

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)